amiodarone has been researched along with 2019 Novel Coronavirus Disease in 13 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)." | 3.96 | Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? ( Laukkanen, JA; Lavie, CJ; Morin, DP; Perez, MV; Perez-Quilis, C; Sanchis-Gomar, F, 2020) |
| "Amiodarone is a drug commonly used to treat and prevent cardiac arrhythmias, but it is often associated with several adverse effects, the most serious of which is pulmonary toxicity." | 2.72 | A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia. ( Aspromonte, N; Cappannoli, L; Crea, F; Massetti, M; Petrolati, E; Rabini, A; Scacciavillani, R; Smargiassi, A; Telesca, A, 2021) |
| "Ventricular tachycardia was detected by electrocardiography." | 1.72 | Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19: A case report. ( Cheng, YC; Lee, IT; Liao, PH; Liu, PY, 2022) |
| "Amiodarone is a common antiarrhythmic drug that is utilised in clinical practice and is associated with pulmonary toxicity." | 1.62 | Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic. ( Azraai, M; Dick, R; McMahon, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 13 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cappellani, D | 1 |
| Torregrossa, L | 1 |
| Papini, P | 1 |
| Poma, AM | 1 |
| Ambrosini, E | 1 |
| De Napoli, L | 1 |
| Materazzi, G | 1 |
| Basolo, F | 1 |
| Bogazzi, F | 1 |
| Liao, PH | 1 |
| Cheng, YC | 1 |
| Liu, PY | 1 |
| Lee, IT | 1 |
| Navarese, EP | 2 |
| Podhajski, P | 1 |
| Andreotti, F | 1 |
| La Torre, G | 1 |
| Gajda, R | 1 |
| Radziwanowski, A | 1 |
| Nowicka, M | 1 |
| Bukowski, P | 1 |
| Gajda, J | 1 |
| Omyła, M | 1 |
| Lackowski, P | 1 |
| Piasecki, M | 1 |
| Jasiewicz, M | 1 |
| Szymański, P | 1 |
| Pietrzykowski, Ł | 1 |
| Michalski, P | 1 |
| Kubica, A | 1 |
| Urbanowicz, I | 1 |
| Orsini, N | 1 |
| Conte, M | 1 |
| Pinkas, J | 1 |
| Brouwer, MA | 1 |
| Kubica, J | 2 |
| Bílek, R | 3 |
| Danzig, V | 3 |
| Grimmichová, T | 3 |
| Vaugeois, JM | 1 |
| Stancioiu, F | 1 |
| Papadakis, GZ | 1 |
| Kteniadakis, S | 1 |
| Izotov, BN | 1 |
| Coleman, MD | 1 |
| Spandidos, DA | 1 |
| Tsatsakis, A | 1 |
| Musci, RL | 1 |
| Frediani, L | 1 |
| Gurbel, PA | 1 |
| Sanchis-Gomar, F | 1 |
| Lavie, CJ | 1 |
| Morin, DP | 1 |
| Perez-Quilis, C | 1 |
| Laukkanen, JA | 1 |
| Perez, MV | 1 |
| Baldi, E | 1 |
| Sechi, GM | 1 |
| Mare, C | 1 |
| Canevari, F | 1 |
| Brancaglione, A | 1 |
| Primi, R | 1 |
| Palo, A | 1 |
| Contri, E | 1 |
| Ronchi, V | 1 |
| Beretta, G | 1 |
| Reali, F | 1 |
| Parogni, PP | 1 |
| Facchin, F | 1 |
| Rizzi, U | 1 |
| Bussi, D | 1 |
| Ruggeri, S | 1 |
| Oltrona Visconti, L | 1 |
| Savastano, S | 1 |
| Cappannoli, L | 1 |
| Telesca, A | 1 |
| Scacciavillani, R | 1 |
| Petrolati, E | 1 |
| Smargiassi, A | 1 |
| Rabini, A | 1 |
| Massetti, M | 1 |
| Crea, F | 1 |
| Aspromonte, N | 1 |
| Kow, CS | 1 |
| Hasan, SS | 1 |
| Azraai, M | 1 |
| McMahon, M | 1 |
| Dick, R | 1 |
| Zizzo, G | 1 |
| Caruso, S | 1 |
| Ricchiuti, E | 1 |
| Turato, R | 1 |
| Stefani, I | 1 |
| Mazzone, A | 1 |
3 reviews available for amiodarone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A dissection of SARS‑CoV2 with clinical implications (Review).
Topics: Amiodarone; Animals; COVID-19; Curcumin; Humans; Pioglitazone; Respiratory Distress Syndrome; SARS-C | 2020 |
Ion channel inhibition against COVID-19: A novel target for clinical investigation.
Topics: Amiodarone; Communicable Disease Control; Coronavirus Infections; COVID-19; Female; Humans; Ion Chan | 2020 |
A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; COVID-19; Diagnosis, Differential; Humans; Lung Diseases, | 2021 |
1 trial available for amiodarone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial.
Topics: Amiodarone; C-Reactive Protein; Carbidopa; COVID-19; Drug Combinations; Humans; Ion Channels; Levodo | 2022 |
9 other studies available for amiodarone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis.
Topics: Amiodarone; COVID-19; Genome, Viral; Humans; Hyperthyroidism; SARS-CoV-2; Thyroidectomy; Thyroiditis | 2022 |
Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19: A case report.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; COVID-19; Electrocardiography; Human | 2022 |
Antiviral activity of amiodarone in SARS-CoV-2 disease.
Topics: Amiodarone; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
Antiviral activity of amiodarone in SARS-CoV-2 disease.
Topics: Amiodarone; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
Antiviral activity of amiodarone in SARS-CoV-2 disease.
Topics: Amiodarone; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
Antiviral activity of amiodarone in SARS-CoV-2 disease.
Topics: Amiodarone; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
Antiviral activity of amiodarone in SARS-CoV-2 disease.
Topics: Amiodarone; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
Antiviral activity of amiodarone in SARS-CoV-2 disease.
Topics: Amiodarone; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
Antiviral activity of amiodarone in SARS-CoV-2 disease.
Topics: Amiodarone; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
Antiviral activity of amiodarone in SARS-CoV-2 disease.
Topics: Amiodarone; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
Antiviral activity of amiodarone in SARS-CoV-2 disease.
Topics: Amiodarone; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
Psychotropics drugs with cationic amphiphilic properties may afford some protection against SARS-CoV-2: A mechanistic hypothesis.
Topics: Amiodarone; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; | 2020 |
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Topics: Amiodarone; Angiotensin-Converting Enzyme 2; Anti-Arrhythmia Agents; Antiviral Agents; Arrhythmias, | 2020 |
Treatment of out-of-hospital cardiac arrest in the COVID-19 era: A 100 days experience from the Lombardy region.
Topics: Aged; Aged, 80 and over; Amiodarone; Betacoronavirus; Cardiopulmonary Resuscitation; Coronavirus Inf | 2020 |
Amiodarone in COVID-19: let's not forget its potential for pulmonary toxicity.
Topics: Amiodarone; COVID-19; Humans; SARS-CoV-2 | 2022 |
Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic.
Topics: Alveolitis, Extrinsic Allergic; Amiodarone; Anti-Arrhythmia Agents; COVID-19; COVID-19 Testing; Dela | 2021 |
Amiodarone-induced organizing pneumonia mimicking COVID-19: a case report.
Topics: Aged; Amiodarone; COVID-19; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Humans; Male; | 2021 |